Maybe tomorrow - once the news breaks.
This could reverse BKL / BAL situation (ie: send BAL up, but BKL down)
After all, BKL's PE is so much higher than BAL even though BKL is technically in a no growth situation.
BAL's SP (like you mentioned) has no growth priced in for FY17... which I find it a bit hard to believe.
- Forums
- ASX - By Stock
- BAL
- There has been no statement from BAL
There has been no statement from BAL, page-14
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BAL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online